BioSpace News Archive

Press Releases

Boehringer Ingelheim’s novel glucagon/GLP-1 dual agonist survodutide achieved significant weight loss of 16.6% delivering meaningful metabolic improvement in people with obesity or overweight in Phase III trial

April 28, 2026
·
14 min read
Press Releases

Theolytics Announces First Patient Dosed in the OCTOPOD-IP Trial, a US Phase 1 Trial with THEO-260, a Novel Oncolytic Immunotherapy Targeting Ovarian Cancer

April 28, 2026
·
3 min read
Press Releases

Ivonescimab Receives Major Recommendations Across Multiple Therapies in the 2026 CSCO NSCLC Guideline

April 28, 2026
·
5 min read
Press Releases

Reacta Healthcare Announces Expansion into Asia-Pacific and Appoints Professor Gary Wing-Kin Wong to Advisory Board

April 28, 2026
·
3 min read
Press Releases

SphingoTec Introduces ELISA sphingotest(R) penKid(R) to Enable Broad Kidney Biomarker Testing for Research Applications

April 28, 2026
·
3 min read
Press Releases

Medtronic announces CE Mark for Stealth AXiS™ surgical system

April 28, 2026
·
4 min read
Press Releases

Anteris Technologies Secures CMS Reimbursement Supporting U.S. Site Activation for PARADIGM Trial

April 28, 2026
·
3 min read
Press Releases

Aclaris Therapeutics Announces Positive Full Top Line First-in-Human Results from Phase 1a Healthy Volunteer Clinical Trial of ATI-052, a Novel Potential First-in-Class Anti-TSLP/IL-4Rα Bispecific Antibody, and Announces Lichen Planus as Lead Indication for ATI-2138, an Oral ITK/JAK3 Inhibitor

April 28, 2026
·
12 min read
Press Releases

Omnicell Announces First Quarter 2026 Financial Results

April 28, 2026
·
19 min read
Press Releases

Immunic Appoints Accomplished Biopharmaceutical Executive Michael A. Panzara, M.D., M.P.H., as Chief Medical Officer

April 28, 2026
·
10 min read